July 26, 2010 APA: Lasting Benefit Seen for TMS in Depression
Relapse rates for patients with treatment-resistant major depression were much lower following transcranial magnetic stimulation (TMS) than is normally seen with drugs or electroconvulsive therapy, researchers said here.
November 10, 2009 Michael J. Fox Foundation Awards $2.2 Million to Four Clinical Trials for New Parkinson's Interventions
Alvaro Pascual-Leone, MD, PhD, of Harvard Medical School will test the potential of noninvasive repetitive transcranial magnetic stimulation (rTMS) to improve both motor and mood symptoms in Parkinson's disease. In October 2008, rTMS was approved by the FDA for the treatment of major depression outside the context of PD. It has also shown promise to alleviate the motor symptoms of Parkinson's. Dr. Pascual-Leone and colleagues, working at four North American sites, will enroll 160 Parkinson's patients whose motor symptoms are significant despite medication and who have been diagnosed with a depressive disorder. The researchers predict that rTMS will improve motor symptoms, depression, or both.